Vestibular side effects in the orbital stage of Skylab II and III missions

None of the six astronauts were motion sick when tested (on or after Mission Day 8) in the workshop under experimental conditions which elicited motion sickness preflight and postflight. Skylab III but not Skylab II astronauts experienced motion sickness under operational conditions aloft. There were individual differences in the severity of the symptoms and susceptibility to motion sickness persisted for three to five days. The discussion centers around the reasons for the greater susceptibility to motion sickness under operational than experimental conditions aloft and the implication of Skylab findings for future manned space missions.